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Abstract To study the fluctuations of cGMP in living cells 
through changes of energy transfer of dissociahle fluorescence 
labeled subunits, we constructed a cGMP-sensitive probe by com- 
bining the N-terminus of the type I regulatory subunit of cAMP- 
dependent protein kinase (PKA) with the cGMP binding sites of 
cGMP-dependent protein kinase Ic~ (PKG). This chimeric regu- 
latory subunit retained PKA-like dimerization and PKG-compat- 
ible cGMP binding constants (K d = 53 nM) for both binding sites. 
High affinity interaction with the PKA catalytic subunit was 
verified by Surface Plasmon Resonance (Kd = 3.15 nM). Addi- 
tionally, the chimera inhibits the formation of wild-type holoen- 
zyme with an apparent K i of 1.05 riM. Furthermore, cGMP 
dissociated the mutant holoenzyme with an apparent activation 
constant of 146 nM. Thus, our construct provides all the require- 
ments needed to investigate changes in intracellular cGMP con- 
centrations. 
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completely reversible, therefore not only rising cAMP concen- 
trations could be measured but also the decrease of the allo- 
steric regulator. In addition, Bacskai et al. [6] found with fluo- 
rescence-labeled PKA that cAMP synthesis after stimulation 
with serotonin is much higher in the processes of Aplysia neu- 
rons than in the cell bodies. Alternatively, the localisation of 
the dissociated subunits could be determined as has been shown 
for the catalytic subunit [7]. The second messenger cGMP 
plays, like cAME an important role in mediating a large num- 
ber of extracellular signals and with the steadily increasing 
number of cellular cGMP-receptors such as cation channels 
and phosphodiesterases [8], its function in regulatory processes 
is less clear than that for cAME Therefore, we constructed a 
cGMP-sensitive r ceptor protein, which can be used as a probe 
to monitor specifically the fluctuation of the cGMP concentra- 
tion inside cells. We describe here the mutagenesis, expression 
and functional analysis of a chimeric regulatory subunit hat 
contained the N-terminal 147 amino acids of PKA kz, including 
the hinge region, and the two cGMP binding sites (aa 115-353) 
of PKG Ic~. 
1. Introduction 
cAMP-dependent protein kinase (PKA) and cGMP-depend- 
ent protein kinase (PKG) are the major cellular receptors for 
cyclic nucleotides. While PKA and PKG share many structural 
features, they differ remarkably in their mechanism of kinase 
activation (for review see [1-3]). The PKA holoenzyme complex 
(R2C2) consists of a regulatory subunit dimer (R2) and two 
catalytic subunit (C) monomers. Binding of two molecules of 
cAMP to each regulatory subunit causes the complex to disso- 
ciate and subsequently o release the active C-subunits. In con- 
trast, in the PKG R- and C-domains are fused in a single 
polypeptide chain and activation of this enzyme involves major 
conformational changes [4]. The unique property of PKA, that 
is, the dissociation of R- and C-subunits during activation 
proved valuable for investigating the subcellular function and 
localization of cAMP inside living cells. After labeling the R- 
and C-subunits with rhodamin and fluorescein, respectively, 
the so formed holoenzyme ((Rh)-R2C2-(F1)) showed strong en- 
ergy transfer between the chromophores and changes of the 
energy transfer upon activation [5]. After microinjecting the 
labeled holoenzyme in living cells this technique allowed to 
measure free cAMP concentrations as a response to extracellu- 
lar stimulation by the use of confocal fluorescence microscopy. 
Adams et al, [5] showed that the change in energy transfer is 
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2. Materials and methods 
2.1. Reagents and materials 
Polyethylenimine cellulose and cAMP-agarose were from Sigma. [?'- 
32P]ATP (4500 Ci/mmol) was from Amersham, whereas [~-35S]dATP 
(1150 Ci/mmol), [8,5'-3H]cGMP (30 Ci/mmol) and [2,8-3H]cAMP (28 
Ci/mmol) were obtained from DuPont. [3H]Cyclic nucleotides were 
purified before use [9]. Nitrocellulose filters (0.45 /IM) were from 
Schleicher & Schuell. 8-Br-cGMP was purchased from BioLog. 
Phosphotransferase assays were performed with Kemptide (Sigma) or 
the synthetic peptide (Ac-RAERRASI-NH2) [10]. Oligonucleotides 
were synthezised on the ABI Syntheziser, model 392 and purified with 
Quiagen kits. Sucrose density gradient centrifugation was performed 
with a Beckman ultracentrifuge (L8-70M) and a VTi 65.1 rotor. En- 
zymes for DNA manipulation were obtained from Boehringer- 
Mannheim, USB, New England Biolabs, or Gibco-BRL. All reagents 
for cloning were of molecular biology grade. All other chemicals, in- 
cluding media, protease inhibitors and reagents used in protein purifi- 
cation, were ofanalytical grade. 
2.2. Mutagenesis 
A BglII restriction site was introduced into pUC 18 R ~, containing 
the coding sequence of the PKA In regulatory subunit [11], by mutating 
nt 433 (A-+T) and nt 434 (G---~C) using PCR overlap extension [12]. 
The PCR reaction mixture (100/zl) contained 10 mM Tris pH 8.3, 1.5 
mM MgCI2, 50 mM KCI, 0.25 mM dNTPs, 1 ng template DNA, 0.25 
mM of primer A: 5'-GACTCCATCGTGCAGCTGTGC-3', and 
B: 5'-GTCAAAAATGTCAGATCTCTCGTTATCAT-3', or primer 
C: 5'-GATAACGAGAGATCTGACATTTTTGA-3', and D: 5'-TTC- 
TGTAGCTGTCCCGGT-3' and 2.5 U Taq-polymerase. The flanking 
primers A and D correspond to nt 91-111 and nt 674-691, whereas the 
mutagenesis primers B and C were complementary to nt419-447. The 
amplified DNA fragments were purified by 6% PAGE and subse- 
quently electroeluted. A second PCR reaction with primers A and D 
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and the two primary PCR products as template gave the final DNA- 
fragment which was cut with Sill and XhoI, ligated into pUC 18 R l and 
electroporated into E. coli XL1 blue (Stratagene). BglIl positive clones 
(pUC 18 WlBgllI) were selected and sequenced according to the 
method escribed by Sanger [13]. The sequence of PKG Is [14] coding 
for the cGMP binding sites (nt 344-1059) was amplified by PCR us- 
ing primer I: 5'-AACGAGAGATCTGACATTGTGGATTGTATGT- 
ACC-3' corresponding to nt 344-363 (containing a BglII site) and 
primer II: 5'-CTAGTCTAGATTAGGCGAAGAAAGCAGC 3' com- 
plementary tont 1045-1059 (introducing a stop codon and a XbaI site). 
The PCR product was cut with BglII and XbaI and ligated into pUC 
18 RqBgllI to yield pUC 18 AG R ~. Transformation was performed by 
electroporation i to E. coli XLI blue and positive clones were se- 
quenced. For expression of the mutant protein, subsequently referred 
to as AG R ~, the gene was subcloned into the Tv-RNA-Polymerase 
dependent pET 3d vector [15]. pUC 18 AG R E was digested with NeoI 
and SalI, while pET 3d was cut with NcoI and BamHI. After ligation 
of the NcoI site, ends were refilled with T4-DNA-polymerase, ligated 
and sequenced. 
2.3. Expression and purification of AG R 1 
Expression of AG R ~ was performed in E. coli BL21 (DE3)(pLysE) 
at 37°C in LB-broth (100/2g/ml ampicillin, 34/2g/ml chloramphenicol) 
[15]. Cells were induced at an OD620 = 0.5 with 0.5 mM IPTG and 
incubated for 2 h. The bacterial pellet was subjected to a French Pres- 
sure Cell and centrifuged. The expressed protein was found in the pellet 
fraction with a yield of approximately 40 mg/l. The inclusion bodies 
were solubilized in 100 mM KPO4-buffer, pH 7.0, 8 M urea, 0.3 M 
fl-mercaptoethanol and 100/2M cAMP for 45 rain at room temperature. 
In order to remove the urea, the supernatant of subsequent centrifuga- 
tion was extensively dialyzed against 100 mM KPO4-buffer, pH 7.0, 15 
mM fl-mercapthoethanol, 1 mM EDTA, 0.2 mM PMSF and 100/2M 
cAMP at room temperature and at 4°C against cAMP free buffer. The 
protein solution was centrifuged and the supernatant loaded on a 
cAMP-agarose column equilibrated with 20 mM KPO4-buffer, pH 7.0, 
100 mM NaC1, 15 mM fl-mercaptoethanol, 2 mM benzamidine, 1 mM 
EDTA, 1 mM PMSF, 43/2M TPCK, 20/2M TLCK. After binding over 
night at 4°C, the column was washed with buffer containing 100 mM 
NaCI, then 0.5 M NaC1 and again with 100 mM NaC1. The protein was 
eluted at room temperature with 1 mM cAMP in running buffer. The 
pooled fractions contained 16 mg purified protein ( = 8 mg/1 culture). 
Protein concentrations were measured according to Bradford [16]. 
2.4. Enzyme assays 
Equillibrium binding (Kd) was determined by a modified method 
described by D~skeland and Ogreid [17]. The chimeric protein was 
incubated at a concentration f 40 nM for cGMP binding (respectively 
200 nM for cAMP binding) in 200/21 binding buffer (50 mM MES, pH 
6.9, 10 mM NaC1, 10 mM DTT, 1 mM Mg-acetate, 0.4 mM EGTA and 
0.5 mg/ml BSA) with varying concentrations of [3H]cGMP or 
[3H]cAMP at 0°C. After 90 rain of incubation, the protein was precip- 
itated with ice-cold 95% ammonium sulfate, filtered over 0.45/2m pore 
size filters, washed with ice-cold 95% ammonium sulfate and counted 
in Triton X-100/toluene scintillation mix. 
cGMP dissociation rates (kd) were determined by saturating 50 nM 
AG R ~ with 250 nM [3H]cGMP during 90 min at 0°C in a final volume 
of 200/21 binding buffer. Dissociation was started by adding 20/11 of 
1 mM cGMP. After designated time points, the reaction was stopped 
with ice-cold 95% ammonium sulfate and treated as described above. 
8-Br-cGMP which selectively binds to the slow dissociating site B [18] 
was added to a final concentration f 10/2M in experiments designated 
to measure the fast dissociating binding site A. 
Kinase activity of holoenzyme preparations was determined by [),- 
32p]ATP phosphotransferase say. The holoenzyme (10 ng/assay) was 
incubated with 50 /2M kemptide, 100 /2M [?-32p]ATP and various 
cGMP concentrations. The phosphotransferase reaction was carried 
out for 3 min at 30°C, according to a method escribed previously [19]. 
2.5. Holoenzyme formation 
Holoenzyme was formed in the presence of 100/2M Mg-ATE The 
regulatory chimera nd the PKA catalytic subunit were dialysed with 
an 2.5 molar excess of chimeric subunit against 40 mM KPO4, pH 6.6, 
15 mM fl-mercaptoethanol, 100 /2M ATE 500 ruM MgC12 and 5% 
glycerol for 24 h [20]. Holoenzyme formation was verified by Surface 
Plasmon Resonance spectroscopy, native PAGE and FPLC chroma- 
tography (see below). 
2.6. Surface Plasmon Resonance 
Surface Plasmon Resonance (SPR) was used to study the interaction 
between the C-subunit and wild type or mutant R-subunits using a 
BIAcore instrument (Pharmacia/Biosensor), SPR detects mass changes 
in real time on a sensor chip surface which was prepared by direct 
coupling of the C-subunit by primary amines to the CM-dextran (Bio- 
sensor Amine Coupling Kit). All proteins were purified by gel filtration 
or affinity chromatography. The experiments were performed as out- 
lined previously [21]. Kinetic constants were calculated by linear egres- 
sion of data, using the BIAcore pseudo-first-order rate equation: 
dR/dt = kas~ x CRm~x-(k~ x C + kdiss ) X R t 
The association rate is kass, kdiss the dissociation rate, C is the concentra- 
tion of the injected analyte and R is the response. Plots of dR/dt vs. Rt 
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Fig. 2. Expression of the chimeric AG RLsubunit in E. coli BL21 (DE3) 
(pLysE). Lane 1 = molecular weight marker, lane 2 = purified AG R ~ 
(2 pg), lane 3 = cells prior to induction (approx. 25 pg), lane 4 = cells 
2 h after induction (approx. 25 pg), lane 5 = French press homogenate, 
Jane 6 = supernatant (15 pg), lane 7 = pellet, lane 8 = refolded protein 
(3 pg), lane 9 = cAMP-agarose flow through (3 pg), lane 10 = cAMP- 
agarose luate (3 pg). In order to show the distribution of AG R ~ in 
pellet and supernatant, the same fraction of total volume as in lane 6 
was loaded in lanes 5 and 7. 
have a slope of k~. When k S is plotted against C the resulting slope is 
equal to ka~s. The kd~ was calculated by integrating the rate equation 
when C = 0, yielding: 
ln(Rt,/Rm) = kji~ × (t,,-t,) 
Affinity constants were calculated from the equation: K d = kd~sJkas s. 
Association and dissociation rate calculations were performed using 
concentrations between 75 nM and 500 nM for wild type R and AG 
R ~ subunit. 
2. 7. Determination of  the apparent inhibition constant Jor holoenzyme 
Jormation 
Recombinant catalytic subunit (0.05 nM in 0.1 ml kinase assay buffer 
containing 50 mM MES, pH 6.9, 10 mM DTT, 10 mM NaCI, 1 mM 
Mg-acetate, 0.4 mM EGTA, 100/aM [y-32p]ATP and l mg/ml BSA) was 
mixed with various concentrations of wild-type regulatory subunit and 
incubated for 15 min at 30°C. After preincubation, holoenzyme forma- 
50 
tion was monitored by determining the remaining catalytic activity for 
15 min as described above (section 2.4). The apparent association con- 
stant (Kd.app) was obtained from plotting the % enzyme activity versus 
log[R-subunit]. The experiment was repeated in the presence of increas- 
ing concentrations of mutant regulatory subunit (2-20 nM). The appar- 
ent K~ was derived from the replot ICs0 versus lAG R I] as shown in 
Fig. 6. 
2.8. Determ&ation of  activation constants by analytical FPLC-gel 
filtration 
Analytical gel filtration was carried out, using a Superdex 200 PS 
Y2130 column on a SMART system (Pharmacia) [22]. All runs were 
done at 22°C in a buffer containing 20 mM MOPS, pH 7.0, 150 mM 
KCI and 1 mM DTT. 560 nM FITC-labeled C-subunit was mixed with 
a 1.5 molar excess of AG R ~ and incubated with different concentra- 
tions of cyclic nucleotides, ranging from 20 nM to 10 pM, for 1 h. For 
each run the column was equilibrated with the appropriate cyclic nucle- 
otide concentration i  the gel filtration buffer. 20 pl of the samples were 
injected onto the gel filtration column and the percentage of holoen- 
zyme at various cyclic nucleotide concentrations was c lculated based 
on the peak areas corresponding to both holoenzyme and C-subunit. 
C-subunit (10 mg/ml) was labeled with fluorescein-5-isothiocyanate 
(FITC) using a 35-fold excess of label [22]. 
2.9. Sucrose density gradient centrifugation 
5-15% sucrose density gradients were used to determine the sw.2o 
values. Centrifugation was carried out at 65 000 rpm for 108 min. 
Proteins (45-300 pg) were dissolved in 20 mM potassium phosphate, 
pH 7.0, 2 mM benzamidine and 2 mM EGTA. Runs with holoenzyme 
contained 100/.*M ATP and 500/.tM MgCI2 but no EGTA. The gradi- 
ents were fractionated into 23 aliquots, analysed for protein concentra- 
tions by either the Bradford assay, cGMP binding or kinase activity. 
The following internal marker proteins were used: phosphorylase b 
(sw,2o = 8.2), y-globulin (rabbit, sw,2o = 6.36), horseradish peroxidase 
(sw,2o = 3.67) and lysozyme (Sw,2o = 1.9). PKA regulatory subunit I was 
run as a control (Sw.2o = 4.7) [23,24]. 
2.10. Polyacrylamid gel electophoresis (PAGE) 
12% SDS-PAGE was done according to Lii.mmli [25]. Native PAGE 
was performed on 6% gels with the following buffer coditions: stacking 
gel = 62.5 mM Tris-HC1, pH 6.8; separating el = 375 mM Tris-HCl, 
pH 8.9; running buffer = 25 mM Tris-HC1, pH 8.8, 52 mM glycine; 
5 × sample buffer -- 312 mM Tris-HC1, pH 6.8, 50% glycerol, 0.05% 
bromphenol blue. For the electrophoresis of holoenzyme the gel and 
running buffer contained 100 pM ATP and 500/.tM MgC12. Native gels 
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were run at 8 mA for 16 h. The gels were stained with Coomassie blue 
R 250. 
3. Results 
3.1. Mutagenesis, expression and purification 
In order to construct he chimera, a BglII site (nt 431-434) 
was introduced into the sequence of the regulatory subunit of 
PKA Ia. Flanking BglII and XbaI sites, which were added to 
the sequence of the cGMP binding sites (nt 344-1059) through 
PCR primers, allowed to substitute the DNA fragment coding 
for the cAMP binding sites by the cGMP binding sites of PKG 
la. Thus the mutant protein contains aa 1-147 of PKA R I and 
aa 115 359 o fPKG Ia (Fig. 1). 
The chimera was subcloned into the Tv-RNA-polymerase- 
dependent vector pET 3d and expressed at 37°C in E. coli 
BL21. High yields of mutant protein could only be obtained if 
the host strain contained the additional plasmid pLysE, coding 
for TT-lysozyme. Apparently the lysozyme is necessary to stabi- 
lize the toxic mutant by reducing the rate of protein synthesis. 
Expression without or low intracellular concentrations of T 7- 
lysozyme, as in E. coli strains containing no pLys plasmid or 
the weakly expressed plasmid pLysD, gave only poor yields of 
mutant protein (data not shown). Incubation for 2 h after 
induction with IPTG yielded approximately 40 mg/1 insoluble 
protein. Lower growth temperatures (30°C) did not increase 
the amount of soluble protein. The inclusion bodies were read- 
ily solubilized in urea and the protein refolded by removing the 
denaturing agent via dialysis. Addition of 100/tM cAMP to the 
renaturation buffer improved the efficiency of refolding (data 
not shown). Dialysis against cAMP free buffer allowed subse- 
quent purification on cAMP-agarose with a final yield of ap- 
proximately 8 mg renatured protein per liter culture. As jugded 
by SDS-PAGE the chimeric protein was purified to apparent 
homogeneity and had an apparent mass of 46 kDa (Fig. 2). A 
similar discrepancy between the calculated mass of 43.9 kDa 
and the apparent mass of 48 kDa has been reported for the 
wild-type RLsubunit [21]. 
3.2. Dimerization 
Since AG R ~ still retains the dimerization region of PKA at 
the N-terminus, we determined the Svedberg constants (Sw.20) 
of the regulatory subunit of PKA and of AG R ~ by sucrose 
density gradient ultracentrifugation. Both proteins comigrated 
in the same fraction (Sw,20 = 4.7), indicating that the conforma- 
tions are very similar (Table 1), hence dimerization is not im- 
paired by the cGMP binding sites. It has been shown that 
R-subunit dimerization occurs through two antiparallel disulfid 
bonds between residues 16 and 37 of each monomere [26]. Thus 
non-reducing conditions i  SDS-PAGE gave a native like 
dimere with an apparent molecular weight of 86 kDa (data not 
shown). 
3.3. Cyclic nucleotide binding properties 
In order to determine the ligand binding characteristics of
AG R ~, we studied cGMP and cAMP binding under equilib- 
rium dissociation conditions. As shown in Fig. 3 and Table 1 
equilibrium cGMP binding studies revealed that the AG R ~ was 
still capable to bind at least 1.5 mol cGMP/mol subunit with 
high affinity (apparent Ko = 53 nM). Scatchard analysis 
showed that unlike native PKG the two binding sites displayed 
no difference in their affinity for cGME Furthermore, the two 
cGMP sites showed no signs of a definite positive cooperativity 
(Hill coefficient -- 1.1). In contrast to native PKG, which binds 
cAMP at micromolar concentrations [27], cAMP binding under 
equilibrium conditions allowed to measure only one binding 
site with an apparent K d of 216 nM (Table 1). The second cyclic 
nucleotide binding site was not detecTable, presumably since 
it had a low affinity for cAME 
cGMP dissociation showed a biphasic pattern, indicative of 
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nM). (B) Replot of the apparent 1Cs0 from Fig. 5A versus the concen- 
tration of AG RLsubunit gave an apparent K~ of 1.05 _+ 0.26 nM. 
two binding sites. The dissociation rates (ko~.) for both sites 
were relatively fast (site A: 6.1 rain -~, site B: 0.31 rain -j 
(Fig. 4, Table 1)). In order to measure the fast dissociating site 
A more correctly, we incubated the protein with 8-Br-cGMP 
which binds to site B over site A with a 3.7-fold preference [18]. 
While the fast site A is quite similar to site A of the native PKG 
(3,7 min -~) [28], the slow site shows a 60-fold increased issoci- 
ation rate (0.31 rain -1vs. 0.005 min-~)[28]. 
3.4. Holoenzyme formation and dissociation 
In order to study the interaction ofAG R ~ with the catalytic 
subunit of PKA, we employed surface plasmon resonance 
(SPR) as the most sensitive method. Native R ] of PKA was used 
as a control in the experiments. Recombinant C-subunit could 
be immobilized readily by amine coupling onto the carboxy- 
methyl surface of a sensorship [21]. First we showed that wild- 
type and mutant R-subunits bound with a stoichiometric rela- 
tionship of 1:1 to the C-subunit surface. Next we verified that 
the complexes were fully dissociated by treatment with 10/~M 
cAMP or 10/~M cGMP respectively, thus completely regener- 
ating the C-subunit surface. The association rate constants 
(ka~) were determined using protein concentrations ranging 
from 75-500 nM. Wild-type and mutant association rate con- 
stants were 1 x 105 M -~ .s -~ and 1.9 x 105M -j .s -t, respectively 
(Table 1). The dissociation rates (kdiss) were calculated after the 
end of an injection. Rates of 2.3 x 10 -5 s -t and 6.06 × 10 -4 s 1 
were determined for the wild-type and the chimeric omplex, 
respectively. From the association and dissociation rate con- 
stants apparent Kd'S of 0.23 nM and 3.15 nM for the wild-type 
R-subunit and AG R ~ were calculated (Table 1). 
Once we had verified that the chimera still retained the capa- 
bility to form a stable high affinity complex with the catalytic 
subunit, we obtained larger amounts of mutant holoenzyme by 
dialyzing AG R ~ and C subunit in a 1 : 1.1 molar ratio according 
to Bubis et al. [26]. When assaying the remaining catalytic 
activity by [32p]phosphorylation of kemptide, as an indicator 
for the degree of holoenzyme formation, we found that AG R ~ 
showed almost no inhibition of the C-subunit. In contrast the 
catalytic activity was completely inhibited within 24 h at 4°C 
by native R ~. When AG Rt/C holoenzyme was electroeluted 
from a non-denaturing gel, it was still catalyticaly active. Hence 
complex fomation of mutant R and C-subunit does not inhibit 
the catalytic activity. Therefore, we tested whether or not AG 
R ~ competed with the wild-type R-subunit for the catalytic 
subunit. Wild-type holoenzyme formation was accomplished at
30°C for 15 min, which is sufficient to completely form the 
complex [29]. Incubation of 0.05 nM catalytic sububit with 
increasing concentrations of R~-subunit was performed as de- 
cribed in section 2. The apparent association constant was 
determined as /Ca = 0.20 nM and is in accordance with the 
published value [29]. The measurement was repeated with in- 
creasing concentrations of mutant R-subunit and the IC50 re- 
plotted to determine the apparent K~ of 1.05 _+ 0.26 nM as 
shown in Fig. 5. In addition, holoenzyme formation was con- 
firmed by non-denaturing gel electrophoresis (data not shown) 
and sucrose gradient ultracentrifugation. The Svedberg con- 
stants (Sw,20) of the mutant holoenzyme differed with 6.83 
slightly from that for PKA holoenzyme (Sw.20 = 7.25) (Table 1). 
It appeared that the complex was only stable when 100/.tM 
Mg-ATP were present. 
In order to determine the holoenzyme dissociation constants 
for cGMP and cAMP, we used analytical FPLC gel filtration 
as described in section 2. As shown in Fig. 6, the mutant 
holoenzyme could be dissociated by the addition of cGMP or 
cAMP with apparent activation constants of K,.coMp : 146 nM 
and KaxAM p = 640 nM. Gel filtration experiments also proved 
a strong tendency of AG R ~ to rebind the catalytic subunit, 
since the xperiments were only successful when the column 
was equilibrated with running buffer containing the appropri- 
ate concentration f cyclic nucleotide. 
4. Discussion 
PKA and PKG display a remarkable similar subdomain or- 
ganisation. Both regulatory domains consist of a N-terminal 
dimerization region, followed by a hinge region which contains 
the primary auto-phosphorylation or inhibition site. C-Termi- 
nal to the hinge, two highly homologues cyclic nucleotide bind- 
ing sites are fused. Apart from the cAMP/cGMP binding do- 
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Fig. 6. K, of AG R I for cGMP and cAME determined by analytical 
FPLC-gelfiltration offree catalytic subunit versus holoenzyme. Mutant 
holoenzyme, which contained fluorescence labelled C-subunit, was dis- 
sociated with increasing concentrations of cGMP or cAME The ratio 
of fluorescence of free to bound catalytic subunit, representing the 
percentage ofactivation, was plotted versus the log of cyclic nucleotide 
concentration to give an activation curve with apparent activation 
constants of 146 nM and 640 nM for cGMP and for cAMP, respec- 
tively. 
mains the two subunits show particularly little homology at 
their N-termini ncluding the hinge regions. While the R-sub- 
unit of PKA I~ dimerizes through two cysteine bonds [26], the 
type Ic¢ PKG apparently dimerizes by the use of a leucine zipper 
interaction [4]. The differences regarding the hinge region of 
PKA and PKG are particularly eminent [1]. Furthermore, PKA 
has a well-defined autoinhibitory site which is indicative of a 
clear structured interaction with the catalytic subunit, whereas 
for PKG the structural nature of the R/C-interaction is less 
obvious. It has been shown that the PKA R-subunit primarily 
interacts with the C-subunit by residues around the consensus 
sequence in the hinge region [30,31]. As judged from the X-ray 
crystal structure of the 1-91 deletion form of the type I0t R- 
subunit of PKA [32], the two nucleotide binding sites form an 
elongated structure apart from the hinge region allowing for 
multiple interactions with the catalytic subunit. 
When we started out to construct a cGMP-sensitive R-sub- 
unit it became apparent hat the construct needed to contain 
as much of the type Ic~ R-subunit sequence of PKA as possible 
to account for most of the interactions responsible to reversibly 
bind the PKA catalytic subunit. The mutant protein (AG R ~- 
subunit) still bound cGMP with high affinity even though the 
cooperativity between the two sites was lost. Apparently, the 
cooperativity is influenced by kinase specific sequences N-ter- 
minal of the binding sites [19,21] and by PKG specific disulfide 
bonds [33]. Most importantly, the AG R'-subunit retained the 
PKA R-subunit specific property to form a stable complex with 
the PKA catalytic subunit. However, the so formed mutant 
holoenzyme complex was still catalytically active. This implies 
that in the native holoenzyme additional interactions are re- 
sponsible to fully inhibit the catalytic activity of the enzyme. It 
was recently suggested that cAMP binding to the PKA holoen- 
zyme does not neccessarily induce dissociation of the subunits 
[34,35]. Instead, the cAMP. RzCz-complex is sufficient to gener- 
ate enzyme activity. The active AG-R ~ holoenzyme was fully 
dissociated upon cGMP binding with an apparent activation 
constant of 146 nM as we could show by analytical FPLC 
gel-filtration (Fig. 6). Thus, the mutant holoenzyme was 
acivated by cGMP just as well as wild-type Ic~ PKG [28]. How- 
ever, cAMP was also capable to activate the complex with an 
apparent activation constant of 640 nM. This suggests that the 
mutant holoenzyme has a diminished cGMP selectivity since 
the wild type I~ PKG has a micromolar activation constant for 
cAMP [36]. In addition we observed a strong Mg-ATP depend- 
ency to stabilize the mutant holoenzyme. 
Mutant holoenzyme dissociation is the most crucial function 
Table 1 
Physical and kinetic constants of PKA type Ic~, PKG type Is and the chimera A/G 
AG R l R' PKA PKG I0~ 
Physical constants 
MW calc. [kD] 42 43.9 [21] 76.4 [14] 
MW SDS-PAGE [kD] 46 48 [21] 75 [28] 
Sw,20 R-subunit 4.7 4.7 
holoenzyme 6.83 7.25 8.0 [19] 
Equilibrium nucleotide binding 
KD (cAMP) [nM] 216 + 5 site A: 60/site B: 15 [21] 
stoichiometry 1 2 
K o (cGMP) [nM] site a and b: 53 + 2.4 - 
stoichiometry 2 
cyclic nucleotide dissociation 
kofr (cAMP) [min '] 
kofr (cGMP) [min '] 
site A: 39 800/site B: 1900 [27] 
2 
site A: 148 site B: 14 [28] 
2 
n.d. site A: 0.6/site B: 0.02 [21] 
site A: 6,1/site B: 0.31 site A: 3.7/site B: 0.005 [28] 
R/C-interaction 
app. ka~ (BIAcore) [M -l s -1] 1.9 × l0 S 1.0 × 105 
app. kdi~ (BIAcore) [s -I] 6.06 x 10 -4 2.3 x 10 -5 
app. Ko (BIAcore) M 3.15 × 10 -9 2.3 x 10 ,0 
K i holo. formation [nM] 1.05 + 0.26 x 10  -9  - 
Enzyme activation 
K, (cAMP) [nM] 640 + 76 105 [21] 
K, (cGMP) [nM] 146 + 6 4100 [37] 
19600 [36] 
100 [28] 
362 N. Wild et al./FEBS Letters 374 (1995) 356-362 
in vivo with regard to changes in fluorescence energy-transfer. 
Thus the AG RLsubunit fulfills all the major requirements for 
a cGMP-sensitive probe which can be used to study intracellu- 
lar cGMP concentrations in living cells by the use of confocal 
fluorescence spectroscopy. We are currently investigating 
methods to chemically inactivate the C-subunit in order to 
circumvent the observed catalytic activity of the AG-R ~ holoen- 
zyme. 
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